Location: Home
  • search
  • go
  • Relate News
  • 12/19/2018Ascentage Pharma Announces Strategic Collaboration with Genor Biopharm...
  • 12/19/2018Auransa and Lee's Pharma Enter Agreement for AU018 in Greater China an...
  • 12/19/2018Pfizer and GSK Announce JV to Create a Global Consumer Healthcare Gian...
  • 12/18/2018New Pfizer CEO's Top Priorities? Think China and Pipeline, Not Deals
  • 12/18/2018Bridge Bio and Daewoong Enter US$40M License Deal for UC Drug Candidat...
  • 12/18/2018Anji Pharma Licenses Regional Rights to a Clinical Asset from Novartis
  • 12/18/2018China's Win-At-All-Costs Approach Suggests It Will Follow Its Own Dang...
  • 12/18/2018Gilead Sciences Takes Off in China with Commitment to Cure Hepatitis
  • 12/18/2018Grifols Eyes $5B Takeover of Shanghai RAAS Blood Products
  • 12/18/2018China's Patent Linkage Plan in Serious Doubt
  • 12/17/2018CDE Seeks Comments on Draft Chinese Translations of 24 ICH Guidelines
  • 12/17/2018FibroGen's Roxadustat Approved in China for Anemia in CKD Patients on ...
  • 12/17/2018I-Mab and CSPC Pharma Announce Strategic Alliance for Long-acting GLP-...
  • 12/17/2018Innovent and Incyte Enter Strategic Partnership for Three Clinical-sta...
  • 12/17/2018Roche Wins Chinese Approval of Anticancer Perjeta (Pertuzumab)
  • 12/17/2018NMPA Seeks Comments on the Second List of Drugs with Expired, Terminat...
  • 12/14/2018Recent Official and Executive Moves
  • 12/14/2018NHC Set to Launch National Adjuvant Drug List Soon
  • 12/13/2018Promising Phase 3 Results For Green Valley’s Alzheimer’s Drug
  • 12/13/2018State Council Passes Final Draft of 4th Amendment of Chinese Patent La...
  • 12/13/2018JW Therapeutics Opens R&D Center in Shanghai
  • 12/13/2018Innovent Announces Positive Outcome of Two Clinical Studies for Avasti...
  • 12/13/2018WuXi AppTec Failed to Shine on HKEx Debut
  • 12/12/2018Zai Lab Announces Acceptance of Its NDA for ZEJULA (Niraparib) in Chin...
  • 12/12/2018IntelGenx Partners with Gensco Pharma to Market RIZAPORT in the U.S. a...
  • 12/12/2018Actelion Granted Chinese Approval for PAH Drug Uptravi (Selexipag)
  • 12/12/2018Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. Just ...
  • 12/12/2018Luye Pharma Files IND for CNS Drug LY03003 in Japan
  • 12/11/2018USFDA Warns Zhejiang Huahai for Failure to Detect Valsartan API Impuri...
  • 12/11/2018Aurobindo Subsidiary and Luoxin Agree to Form Chinese JV
  • Page:300/775 Total number of articles:23243: [First][<<] [298] [299] [300] [301] [302] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group